Valneva : No turn-around in sight
Entry price | Target | Stop-loss | Potential |
---|
€6.34 |
€7.8 |
€5.2 |
+23.03% |
---|
Shares in Valneva SE show a positive technical chart pattern over the medium term, which suggests that the rising trend should be followed.
Strengths● According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
● The company is in a robust financial situation considering its net cash and margin position.
● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
● Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● Within the weekly time frame the stock shows a bullish technical configuration above the support level at 3.45 EUR
Weaknesses● The company has insufficient levels of profitability.
● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
● The company's enterprise value to sales, at 4.37 times its current sales, is high.
● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
● For the past year, analysts have significantly revised downwards their profit estimates.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.